top of page
IMG_4917.jpg

ENGINEERING IMMUNITY

Home: Welcome
Untitled (1)_edited.jpg

REPROGRAMMING B CELLS FOR NEXT GENERATION VACCINES AND GENE THERAPIES

Home: About
Copy of Copy of Untitled-9.png

REPROGRAMMING B CELLS FOR MAB DEVELOPMENT AND IMMUNOGEN TESTING

Home: About

OUR TEAM

Home: Text
James Voss.jpg

JAMES VOSS, PH.D.

Principle Investigator

Welcome to our website! I am an Institute Investigator in the Department of Immunology and Microbiology at Scripps Research in La Jolla California. I did my PhD in Structural Virology at the Institut Pasteur in Paris, France. My postdoctoral work was here at Scripps with Dr. Dennis Burton studying the antibody response to HIV and how protective HIV broadly neutralizing antibodies might be induced through vaccination. Because such antibody genes are so difficult to elicit from the natural human B cell repertoire, my lab is now interested in generating them from genome modified B cells. Our vision is to reprogram the B cell antigen receptor using CRISPR-cas and then to generate durable multi-specific broadly neutralizing antibody memory responses from such cells that would be capable of suppressing the virus in infected patients as a functional cure approach. While this is our main passion, we believe that engineered B cells will be broadly useful, transforming immunotherapy and even the treatment of genetic diseases like hemophilia. They can be used to help solve unanswered questions about B cell biology and the antibody response. We are also using them to perform directed evolution and to explore affinity maturation pathways in vitro. Finally, we are also especially motivated to develop biotechnologies that will make engineered B cell-based therapies inexpensive and accessible to all who may need them.

bhange

DISHA BHANGE, PH.D.

Postdoctoral Associate

Originally from India, I completed my Ph.D. from JNCASR, Bangalore where my work was primarily focused on studying HIV-1 latency with respect to variations in the promoter of the virus. I joined the Voss lab as a postdoctoral associate. Our group has grown into a very supportive working environment with people from diverse backgrounds and expertise. Currently, I am using CRISPR tools to generate "B-cell engineering vaccines" that aim to elicit HIV broadly neutralizing antibodies in pre-clinical animal models as an HIV cure approach. My dream is to carry promising models forward towards human clinical trials.  Besides research, I enjoy performing arts, cooking, and love interacting with new people.

tenuta

MARY TENUTA

Graduate Student

Hello! I’m Mary and I’m originally from New York. I moved to San Diego to complete my undergraduate studies and graduated with a B.A. in Biology from the University of San Diego in 2018. I started working in the Voss lab in 2019 as a technician and then joined the lab as a graduate student in 2020. For my thesis, I am developing CRISPR-Cas9 modified rhesus macaque B cells that express HIV broadly neutralizing antibodies as antigen receptors. We are autologously engrafting and vaccinating these cells in order to elicit HIV bnAB memory responses which we can evaluate in the context of infection as cure approach. This project really embodies my main career aspiration which is to develop cutting edge genome editing technologies to improve human health for all. When I’m not in the lab, you can find me cheffing it up in the kitchen, catching live music, or on the tennis court.

ahn

JOON HYUNG AHN

Graduate Student

I've done my undergraduate in biology and chemistry, and masters in chemistry in Korea, working with peptides and proteins. Here, I am mainly focusing on double targeting mouse B cells to elicit more robust/durable bnAb expression, or bi- or tri-specific bnAbs in our engineered B cells. I am also working on in vitro affinity maturation system in cell lines and figuring out the fate of our engineered mouse B cells. I usually hit the gym, play some games when I am not in the lab.

144200.jpg

TANAKA REMBA

Graduate Student

Hello! My name is Tanaka Remba and I am an aspiring immunoscientist. My long-term professional goals include leading a lab and conducting research at the interface of immunological engineering and science to improve medicine, biology, and overall human health. I hope to be involved in the clinical translation of immunotherapies so that they can be eventually made available to patients worldwide. When I am not dreaming about saving the world, I am chasing sunsets, experimenting with new recipes, feeding friends, traveling, or napping. My retirement plan is to open a restaurant that serves the foods I crave on that particular day so there is neither a set cuisine or menu.

harris

MORGAN HARRIS

Graduate Student

I received a B.A. in Biology from Williams College in 2020. Prior to Scripps, I supported the COVID Convalescent-Plasma Expanded Access Program at Hennepin County Medical Center in Minneapolis and investigated the immune responses to malaria in the joint labs of Dr. Anne Frosch and Dr. Kristina Burrack. My time working with patients gave me valuable perspective on the human impact of research and fostered my desire to study HIV.

olson

ALEX OLSON

Research Assistant

Hello!  I'm Alex, originally a Vermonter who found his way to San Diego in 2018.  I've been in the Voss group for 4 years now, focusing mainly on our mouse B cell engineering and recombinant protein pipelines.  When I'm not at work you can find me cooking, dancing at concerts, playing piano, and doing yoga (all at the same time, of course).  I also love time spent outside and enjoying the beauty our city has to offer, made all the more fun with my newly adopted dogs.

Home: What We Do

PUBLICATIONS

Home: Text
trimer

Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells  Deli Huang, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mariia V. Guryleva, Mary Tenuta, Roberta P. Fuller, Torben Schiffner, Justin R. Abadejos, Lauren Couvrette, Tanya R. Blane, Karen Saye, Wenjuan Li, Elise Landais, Alicia Gonzalez Martin, William Schief, Ben Murrell, Dennis R. Burton, David Nemazee, James E. Voss doi: https://doi.org/10.1101/2020.03.17.989699

Reprogramming the antigen specificity of B cells using genome-editing technologies. Voss JE, Gonzalez-Martin A, Andrabi R, Fuller RP, Murrell B, McCoy LE, Porter K, Huang D, Li W, Sok D, Le K, Briney B, Chateau M, Rogers G, Hangartner L, Feeney AJ, Nemazee D, Cannon P, Burton DR.Elife. 2019 Jan 17;8:e42995. doi: 10.7554/eLife.42995.PMID: 30648968

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nahmad AD, Lazzarotto CR, Zelikson A, Justin T, Tenuta M, Huang D, Reuveni I, Nataf D, Raviv Y, Horowitz-Fried M, Dotan I, Carmi Y, Rosen-Arbesfeld R, Nemazee D, Voss JE, Stern A, Tsai SQ, Barzel A. Nature Biotecdhnology 40, 1241-1249 (2022)

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He WT, Limbo O, Smith C, Song G, Woehl J, Yang L, Abbott RK, Callaghan S, Garcia E, Hurtado J, Parren M, Peng L, Ramirez S, Ricketts J, Ricciardi MJ, Rawlings SA, Wu NC, Yuan M, Smith DM, Nemazee D, Teijaro JR, Voss JE, Wilson IA, Andrabi R, Briney B, Landais E, Sok D, Jardine JG, Burton DR.Science. 2020 Jun 15:eabc7520. doi: 10.1126/science.abc7520. Online ahead of print.PMID: 32540903

Broad neutralization of SARS-related viruses by human monoclonal antibodies. Wec AZ, Wrapp D, Herbert AS, Maurer DP, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, Champney E, Burnina I, Brown M, Lin S, Sinclair M, Johnson C, Pudi S, Bortz R 3rd, Wirchnianski AS, Laudermilch E, Florez C, Fels JM, O'Brien CM, Graham BS, Nemazee D, Burton DR, Baric RS, Voss JE, Chandran K, Dye JM, McLellan JS, Walker LM.Science. 2020 Jun 15:eabc7424. doi: 10.1126/science.abc7424. Online ahead of print.PMID: 32540900

HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite. Nogal B, McCoy LE, van Gils MJ, Cottrell CA, Voss JE, Andrabi R, Pauthner M, Liang CH, Messmer T, Nedellec R, Shin M, Turner HL, Ozorowski G, Sanders RW, Burton DR, Ward AB.Sci Adv. 2020 Jun 5;6(23):eaba0512. doi: 10.1126/sciadv.aba0512. eCollection 2020 Jun.PMID: 32548265 

HIV-1 vaccine design through minimizing envelope metastability. He L, Kumar S, Allen JD, Huang D, Lin X, Mann CJ, Saye-Francisco KL, Copps J, Sarkar A, Blizard GS, Ozorowski G, Sok D, Crispin M, Ward AB, Nemazee D, Burton DR, Wilson IA, Zhu J.Sci Adv. 2018 Nov 21;4(11):eaau6769. doi: 10.1126/sciadv.aau6769. eCollection 2018 Nov.PMID: 30474059

PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. Gavin AL, uang D, Huber C, MÃ¥rtensson A, Tardif V, Skog PD, Blane TR, Thinnes TC, Osborn K, Chong HS, Kargaran F, Kimm P, Zeitjian A, Sielski RL, Briggs M, Schulz SR, Zarpellon A, Cravatt B, Pang ES, Teijaro J, de la Torre JC, O'Keeffe M, Hochrein H, Damme M, Teyton L, Lawson BR, Nemazee D.Nat Immunol. 2018 Sep;19(9):942-953. doi: 10.1038/s41590-018-0179-y. Epub 2018 Aug 13.PMID: 30111894

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Voss JE, Andrabi R, McCoy LE, de Val N, Fuller RP, Messmer T, Su CY, Sok D, Khan SN, Garces F, Pritchard LK, Wyatt RT, Ward AB, Crispin M, Wilson IA, Burton DR.Cell Rep. 2017 Oct 3;21(1):222-235. doi: 10.1016/j.celrep.2017.09.024.PMID: 28978475

Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development. Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR.Immunity. 2017 Nov 21;47(5):1004. doi: 10.1016/j.immuni.2017.10.012.PMID: 29166578

Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines. Voss JE, Macauley MS, Rogers KA, Villinger F, Duan L, Shang L, Fink EA, Andrabi R, Colantonio AD, Robinson JE, Johnson RP, Burton DR, Haase AT.AIDS. 2016 Oct 23;30(16):2427-2438. doi: 10.1097/QAD.0000000000001199.PMID: 27428745 

Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. McCoy LE, van Gils MJ, Ozorowski G, Messmer T, Briney B, Voss JE, Kulp DW, Macauley MS, Sok D, Pauthner M, Menis S, Cottrell CA, Torres JL, Hsueh J, Schief WR, Wilson IA, Ward AB, Sanders RW, Burton DR.Cell Rep. 2016 Aug 30;16(9):2327-38. doi: 10.1016/j.celrep.2016.07.074. Epub 2016 Aug 18.PMID: 27545891 

Mucosal Humoral Immune Response to SIVmac239∆nef Vaccination and Vaginal Challenge. Zeng M, Smith AJ, Shang L, Wietgrefe SW, Voss JE, Carlis JV, Li Q, Piatak M Jr, Lifson JD, Johnson RP, Haase AT.J Immunol. 2016 Mar 15;196(6):2809-18. doi: 10.4049/jimmunol.1500156. Epub 2016 Feb 10.PMID: 26864031

Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design. Andrabi R, Voss JE, Liang CH, Briney B, McCoy LE, Wu CY, Wong CH, Poignard P, Burton DR.Immunity. 2015 Nov 17;43(5):959-73. doi: 10.1016/j.immuni.2015.10.014.PMID: 26588781 

Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry. Li Q, Zeng M, Duan L, Voss JE, Smith AJ, Pambuccian S, Shang L, Wietgrefe S, Southern PJ, Reilly CS, Skinner PJ, Zupancic ML, Carlis JV, Piatak M Jr, Waterman D, Reeves RK, Masek-Hammerman K, Derdeyn CA, Alpert MD, Evans DT, Kohler H, Müller S, Robinson J, Lifson JD, Burton DR, Johnson RP, Haase AT.J Immunol. 2014 Sep 15;193(6):3113-25. doi: 10.4049/jimmunol.1400820. Epub 2014 Aug 18.PMID: 25135832 

Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, Ermonval M, Larquet E, Charneau P, Krey T, Mégret F, Guittet E, Rey FA, Flamand M.Proc Natl Acad Sci U S A. 2011 May 10;108(19):8003-8. doi: 10.1073/pnas.1017338108. Epub 2011 Apr 25.PMID: 21518917

Correct assembly of iron-sulfur cluster FS0 into Escherichia coli dimethyl sulfoxide reductase (DmsABC) is a prerequisite for molybdenum cofactor insertion. Tang H, Rothery RA, Voss JE, Weiner JH.J Biol Chem. 2011 Apr 29;286(17):15147-54. doi: 10.1074/jbc.M110.213306. Epub 2011 Feb 26.PMID: 21357619

Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA.Nature. 2010 Dec 2;468(7324):709-12. doi: 10.1038/nature09555.PMID: 21124458

Home: List
bottom of page